A Conformationally Frozen Peptoid Boosts CXCR4 Affinity and Anti-HIV Activity

被引：47
|
作者：
Demmer, Oliver [1 ,2 ]
Frank, Andreas O. [1 ,2 ]
Hagn, Franz [1 ,2 ]
Schottelius, Margret [3 ]
Marinelli, Luciana [4 ]
Cosconati, Sandro [5 ]
Brack-Werner, Ruth [6 ]
Kremb, Stephan [6 ]
Wester, Hans-Juergen [3 ]
Kessler, Horst [1 ,2 ]
机构：
[1] Tech Univ Munich, Inst Adv Study, Dept Chem, D-85748 Garching, Germany
[2] King Abdulaziz Univ, Dept Chem, Fac Sci, Jeddah 21589, Saudi Arabia
[3] Lehrstuhl Pharmazeut Radiochem, Garching, Germany
[4] Univ Naples Federico II, Dipartimento Chim Farmaceut & Tossicol, Naples, Italy
[5] Univ Naples 2, Dipartimento Sci Ambientali, Caserta, Italy
[6] Helmholtz Zentrum Munchen, Inst Virol Neuherberg, Neuherberg, Germany
来源：
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION | 2012年 / 51卷 / 32期
关键词：
biological activity; drug design; medicinal chemistry; peptides; peptidomimetics; CHEMOKINE RECEPTOR CXCR4; PEPTIDES; AMD3100; ANTAGONISTS; DISCOVERY; INFECTION; LIGAND; CELLS; LESTR/FUSIN; INHIBITORS;
D O I：
10.1002/anie.201202090
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：8110 / 8113
页数：4
相关论文
共 50 条
  • [21] Anti-HIV Small-Molecule Binding in the Peptide Subpocket of the CXCR4:CVX15 Crystal Structure
    Cox, Bryan D.
    Prosser, Anthony R.
    Katzman, Brooke M.
    Alcaraz, Ana A.
    Liotta, Dennis C.
    Wilson, Lawrence J.
    Snyder, James P.
    CHEMBIOCHEM, 2014, 15 (11) : 1613 - 1619
  • [22] Anti-HIV activity profile of a novel CCR5 inhibitor, AMD887, in combination with the CXCR4 inhibitor AMD070
    Schols, D
    Vermeire, K
    Hatse, S
    Princen, K
    De Clercq, E
    Calandra, G
    Fricker, S
    Nelson, K
    Labrecque, J
    Bogucki, D
    Zhou, Y
    Skerlj, R
    Bridger, G
    ANTIVIRAL RESEARCH, 2004, 62 (02) : A37 - A38
  • [23] Anti-angiogenic activity of the CXCR4 antagonist balixafortide
    Zimmermann, Johann
    Obrecht, Daniel
    Remus, Tobias
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [24] HIV coreceptor CXCR4 antagonists
    Schols, Dominique
    CURRENT OPINION IN HIV AND AIDS, 2006, 1 (05) : 361 - 366
  • [25] Discovery of non-peptide small molecular CXCR4 antagonists as anti-HIV agents: Recent advances and future opportunities
    Zhang, Heng
    Kang, Dongwei
    Huang, Boshi
    Liu, Na
    Zhao, Fabao
    Zhan, Peng
    Liu, Xinyong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 114 : 65 - 78
  • [26] A novel dual-luciferase assay for anti-HIV drug screening based on the CCR5/CXCR4 promoters
    Feng, Long
    Lu, Wuhao
    Ma, Yunyun
    Guo, Wentao
    Wang, Yuanyuan
    Sun, Qianqian
    Wu, Jianbo
    Zhao, Guoqiang
    Zhang, Xiaoli
    JOURNAL OF VIROLOGICAL METHODS, 2018, 256 : 17 - 23
  • [27] Anti-HIV activity of quassinoids
    Okano, M
    Fukamiya, N
    Tagahara, K
    Cosentino, M
    Lee, TTY
    MorrisNatschke, S
    Lee, KH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (06) : 701 - 706
  • [28] ANTI-HIV ACTIVITY OF PROTOPORPHYRIN
    ASANAKA, M
    KURIMURA, T
    TOYA, H
    OGAKI, J
    KATO, Y
    AIDS, 1989, 3 (06) : 403 - 404
  • [29] A low-molecular-weight inhibitor against the chemokine receptor CXCR4: A strong anti-HIV peptide T140
    Tamamura, H
    Xu, YO
    Hattori, T
    Zhang, XY
    Arakaki, R
    Kanbara, K
    Omagari, A
    Otaka, A
    Ibuka, T
    Yamamoto, N
    Nakashima, H
    Fujii, N
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 253 (03) : 877 - 882
  • [30] ANTI-HIV ACTIVITY OF COSALANE
    CHOO, V
    LANCET, 1993, 342 (8873): : 733 - 733
12345